Effects of estrogen and alendronate on sister chromatid exchange (SCE) frequencies in postmenopausal osteoporosis patients

Gibaldi, 1997, Prevention and treatment of osteoporosis: does the future belong to hormone replacement therapy?, J Clin Pharmacol, 37, 1087, 10.1002/j.1552-4604.1997.tb04292.x McClung, 1998, Alendronate prevents postmenopausal bone loss in women without osteoporosis, Ann Int Med, 128, 253, 10.7326/0003-4819-128-4-199802150-00001 Hundal, 1997, Genotoxic potential of estrogens, Mutat Res, 389, 173, 10.1016/S1383-5718(96)00144-1 Dhillon, 1995, Genotoxicity evaluation of estradiol, Mutat Res, 345, 87, 10.1016/0165-1218(95)90073-X Patel, 1996, Current and potential future drug treatments for osteoporosis, Ann Rheum Dis, 55, 700, 10.1136/ard.55.10.700 Tucker, 1996, Chromosome aberrations, micronuclei, aneuploidy, sister chromatid exchanges, and cancer risk assessment, Mutat Res, 365, 147, 10.1016/S0165-1110(96)90018-4 Latt, 1981, Sister chromatid exchanges: a report of the Gene-Tox program, Mutat Res, 87, 17, 10.1016/0165-1110(81)90003-8 Perry, 1975, Cytological detection of mutagen-carcinogen exposure by sister chromatid exchange, Nature, 258, 121, 10.1038/258121a0 Ekmekçi, 1995, In vitro effects of prostaglandin E1 and indomethacin on mitomycin C-induced sister chromatid exchanges in mitogen-stimulated human lymphocytes, Mutat Res, 328, 49, 10.1016/0027-5107(94)00196-C Bal, 1998, The in vitro effect of β-carotene and mitomycin C on SCE frequency in Down's syndrome lymphocyte cultures, Tohoku J Exp Med, 184, 295, 10.1620/tjem.184.295 Verma, 1989, Sister chromatid differentiation, Human chromosomes manual of basic techniques, 124 Perry, 1974, New Giemsa method for the differential staining of sister chromatids, Nature, 251, 156, 10.1038/251156a0 Liehr, 1990, Genotoxic effects of estrogens, Mutat Res, 238, 269, 10.1016/0165-1110(90)90018-7 Session, 1993, Current concepts in estrogen replacement therapy in the menopause, Fertil Steril, 59, 277, 10.1016/S0015-0282(16)55667-2